539 related articles for article (PubMed ID: 18347221)
1. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.
Spiel AO; Gilbert JC; Jilma B
Circulation; 2008 Mar; 117(11):1449-59. PubMed ID: 18347221
[TBL] [Abstract][Full Text] [Related]
2. Role of von Willebrand factor in vascular disease.
Paulinska P; Spiel A; Jilma B
Hamostaseologie; 2009 Jan; 29(1):32-8. PubMed ID: 19151843
[TBL] [Abstract][Full Text] [Related]
3. [Von Willebrand factor in coronary disease].
Soskin P; Wiesel ML; Mossard JM; Arbogast R; Najib K; Grunebaum L; Sacrez A; Cazenave JP
Arch Mal Coeur Vaiss; 1994 Jan; 87(1):85-93. PubMed ID: 7811156
[TBL] [Abstract][Full Text] [Related]
4. [High shear stress induced platelet aggregation (h-SIPA) and effects of antiplatelet therapy].
Isaka N; Tanigawa T; Nishikawa M; Nakano T
Nihon Rinsho; 1998 Oct; 56(10):2624-9. PubMed ID: 9796329
[TBL] [Abstract][Full Text] [Related]
5. Role of von Willebrand factor for the onset of arterial thrombosis.
Goto S
Clin Lab; 2001; 47(7-8):327-34. PubMed ID: 11499793
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentration of von Willebrand factor in acute myocardial infarction.
Sakai H; Goto S; Kim JY; Aoki N; Abe S; Ichikawa N; Yoshida M; Nagaoka Y; Handa S
Thromb Haemost; 2000 Aug; 84(2):204-9. PubMed ID: 10959690
[TBL] [Abstract][Full Text] [Related]
8. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Lee KW; Blann AD; Lip GY
Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
[TBL] [Abstract][Full Text] [Related]
9. Role of platelets in the pathophysiology of acute coronary syndrome.
Massberg S; Schulz C; Gawaz M
Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
[TBL] [Abstract][Full Text] [Related]
10. Interaction between inflammation and thrombosis in acute coronary syndrome.
Lytvyn OI; Kopitsa MP; Petyunina OV
Kardiol Pol; 2004 Aug; 61(8):110-6; discussion 114-6. PubMed ID: 15457277
[TBL] [Abstract][Full Text] [Related]
11. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
Chan NN; Fuller JH; Rubens M; Colhoun HM
Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis and thrombolysis: platelet membrane glycoproteins.
Skinner MP
Heart Lung Circ; 2007 Jun; 16(3):176-9. PubMed ID: 17446123
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery disease: pathogenesis and acute coronary syndromes.
Worthley SG; Osende JI; Helft G; Badimon JJ; Fuster V
Mt Sinai J Med; 2001 May; 68(3):167-81. PubMed ID: 11373689
[TBL] [Abstract][Full Text] [Related]
15. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
Jaeger BR; Labarrere CA
Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
[TBL] [Abstract][Full Text] [Related]
16. Detection of von Willebrand factor and tissue factor in platelets-fibrin rich coronary thrombi in acute myocardial infarction.
Yamashita A; Sumi T; Goto S; Hoshiba Y; Nishihira K; Kawamoto R; Hatakeyama K; Date H; Imamura T; Ogawa H; Asada Y
Am J Cardiol; 2006 Jan; 97(1):26-8. PubMed ID: 16377278
[TBL] [Abstract][Full Text] [Related]
17. [von Willebrand's disease and coronary atherosclerosis. Apropos of 3 cases].
Dulhoste MN; Bonnet J; Vergnes C; Choussat A; Bricaud H
Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1875-8. PubMed ID: 2514640
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
[TBL] [Abstract][Full Text] [Related]
19. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.
Spiel AO; Mayr FB; Ladani N; Wagner PG; Schaub RG; Gilbert JC; Jilma B
Platelets; 2009 Aug; 20(5):334-40. PubMed ID: 19637097
[TBL] [Abstract][Full Text] [Related]
20. Effects of von Willebrand factor concentration and platelet collision on shear-induced platelet activation.
Gao Z; Liu F; Yu Z; Bai X; Yang C; Zhuang F; Ruan C
Thromb Haemost; 2008 Jul; 100(1):60-8. PubMed ID: 18612539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
